Yang Zhang provides economic and financial analysis and expert support in all phases of commercial litigation, with a focus on life sciences and antitrust matters.
Academic research and presentations
- “Human Capital, Household Capital and Asset Returns,” with Yu Ren and Yufei Yuan, Journal of Banking and Finance 42 (2014).
- “Market Exclusivity, Entry, and Consumer Welfare: The Case of Rx-to-OTC Switch in the Anti-ulcer Drug Market,” Rising Star Session, International Industrial Organization Conference, April 7, 2017, Boston, MA.
T-Mobile/Sprint Merger Approved